Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Prolymphocytic, T-Cell × ibrutinib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 25 Lymphoma, Mantle-Cell 12 Lymphoma, Non-Hodgkin 9 Lymphoma, Large B-Cell, Diffuse 8 Waldenstrom Macroglobulinemia 5 Lymphoma, Follicular 5 Neoplasms 4 Lymphoma 4 Recurrence 3 Lymphoma, B-Cell, Marginal Zone 3 Burkitt Lymphoma 3 Lymphoma, B-Cell 2 Leukemia, Hairy Cell 2 Hematologic Neoplasms 2 Hematologic Diseases 2 Bronchiolitis Obliterans Syndrome 2 Prostatic Neoplasms, Castration-Resistant 1 Primary Central Nervous System Lymphoma (PCNSL) 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoproliferative Disorders 1 Lymphoma, AIDS-Related 1 Lymphatic Diseases 1 Leukemia, Prolymphocytic 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphoid 1 Leukemia, B-Cell 1 Leukemia 1

Interventions

ruxolitinib 2 duvelisib 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡